Thoracic and Gastrointestinal Oncology Branch, CCR
National Cancer Institute
United States of America
Dr. Raffit Hassan is a medical oncologist and senior investigator at NCI. He received his medical degree from the University of Kashmir, India in 1988 and did his internship and residency training in internal medicine at Sisters Hospital, University of Buffalo and subsequently completed his medical oncology fellowship at the NCI. After finishing his fellowship training he joined the medical faculty at the University of Oklahoma in 1998. He returned to NCI as a tenure track investigator in 2002 and received tenure in 2008. Dr. Hassan is a recipient of the ASCO Career Development Award, the NIH Patient Oriented Research Career Development Award and the Pioneer Award from the Mesothelioma Foundation.
1. Developing targeted immunotherapy, especially immunotoxins, for patients with malignant mesothelioma and other solid tumors 2. Mesothelioma, 3. Mesothelin, 4. Immunotoxins, 5. Immunotherapy, 6. Lung cancer, 7. Pancreatic cancer
Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers.
Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppressio
Discovery of mesothelin and exploiting it as a target for immunotherapy.